Michael F. Huang Soleno Therapeutics Inc (SLNO) insider trading activity

SLNO Quotes by TradingView

Michael F. Huang is Sr. VP of Clinical Development of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 46,405 shares of SLNO, which is worth approximately $2.29 Million. The most recent transaction as insider was on Jan 21, 2026, when has been sold 10,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.4K
26.04% 3M change
12.09% 12M change
Total Value Held $2.29 Million

Michael F. Huang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2026
BUY
Grant, award, or other acquisition
-
10,400 Added 18.31%
46,405 Common Stock
Dec 15 2025
SELL
Payment of exercise price or tax liability
$40,559 $49.95 p/Share
812 Reduced 2.21%
36,005 Common Stock
Mar 27 2025
SELL
Open market or private sale
$1,011,476 $69.36 p/Share
14,583 Reduced 28.37%
36,817 Common Stock
Mar 27 2025
BUY
Exercise of conversion of derivative security
$219,300 $21.93 p/Share
10,000 Added 17.6%
46,817 Common Stock
Jan 21 2025
BUY
Grant, award, or other acquisition
-
6,400 Added 13.39%
41,400 Common Stock
Jul 17 2024
BUY
Grant, award, or other acquisition
-
35,000 Added 50.0%
35,000 Common Stock
MFH

Michael F. Huang

Sr. VP of Clinical Development
Redwood City, CA

Track Institutional and Insider Activities on SLNO

Follow SOLENO THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLNO shares.

Notify only if

Insider Trading

Get notified when an Soleno Therapeutics Inc insider buys or sells SLNO shares.

Notify only if

News

Receive news related to SOLENO THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SLNO